[
  {
    "ts": null,
    "headline": "IAT: Complacent Lending Is Common In Late-Cycle Environments",
    "summary": "IAT faces elevated volatility after credit concerns at Zions Bancorp and Western Alliance Bancorp triggered a sector-wide selloff. Read my analysis of IAT ETF.",
    "url": "https://finnhub.io/api/news?id=4fadc972b808f8e38ef4455759178ccb1bc6dc5e7b325c982b35a653bb11b63f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761075641,
      "headline": "IAT: Complacent Lending Is Common In Late-Cycle Environments",
      "id": 137183389,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2192027463/image_2192027463.jpg?io=getty-c-w1536",
      "related": "TFC",
      "source": "SeekingAlpha",
      "summary": "IAT faces elevated volatility after credit concerns at Zions Bancorp and Western Alliance Bancorp triggered a sector-wide selloff. Read my analysis of IAT ETF.",
      "url": "https://finnhub.io/api/news?id=4fadc972b808f8e38ef4455759178ccb1bc6dc5e7b325c982b35a653bb11b63f"
    }
  },
  {
    "ts": null,
    "headline": "Analysts Remain Bullish on Peloton Interactive, Inc. (PTON) as Company Balances Revenue Growth and Efficiency",
    "summary": "Coatue Management holds $17.35 million worth of shares in Peloton Interactive, Inc. (NASDAQ:PTON), representing 0.05% of its total 13F portfolio, helping the stock secure a place on our list of billionaire Philippe Laffont’s 10 stock picks with huge upside potential. On October 8, 2025, Truist Securities reiterated its “Buy” rating on Peloton Interactive, Inc. (NASDAQ:PTON) […]",
    "url": "https://finnhub.io/api/news?id=ffba4eb5b86c887b1cdb07680b17315ed09d8a67933a66118fef9811d1018d65",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761064265,
      "headline": "Analysts Remain Bullish on Peloton Interactive, Inc. (PTON) as Company Balances Revenue Growth and Efficiency",
      "id": 137180889,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Coatue Management holds $17.35 million worth of shares in Peloton Interactive, Inc. (NASDAQ:PTON), representing 0.05% of its total 13F portfolio, helping the stock secure a place on our list of billionaire Philippe Laffont’s 10 stock picks with huge upside potential. On October 8, 2025, Truist Securities reiterated its “Buy” rating on Peloton Interactive, Inc. (NASDAQ:PTON) […]",
      "url": "https://finnhub.io/api/news?id=ffba4eb5b86c887b1cdb07680b17315ed09d8a67933a66118fef9811d1018d65"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Inc. (VTRS) Acquires Aculys Pharma, Inc",
    "summary": "​Viatris Inc. (NASDAQ:VTRS) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 15, Viatris Inc. (NASDAQ:VTRS) announced completing the acquisition of Aculys Pharma, Inc., which is a clinical-stage biopharmaceutical company. ​Aculys Pharma, Inc. is commercializing innovative treatments for neurological conditions. Management noted that, as a result of this acquisition, […]",
    "url": "https://finnhub.io/api/news?id=e18f1aad372002f6f1de6bb282fbff19302e111480270217bdb79caea5beae70",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761040378,
      "headline": "Viatris Inc. (VTRS) Acquires Aculys Pharma, Inc",
      "id": 137178457,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "​Viatris Inc. (NASDAQ:VTRS) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 15, Viatris Inc. (NASDAQ:VTRS) announced completing the acquisition of Aculys Pharma, Inc., which is a clinical-stage biopharmaceutical company. ​Aculys Pharma, Inc. is commercializing innovative treatments for neurological conditions. Management noted that, as a result of this acquisition, […]",
      "url": "https://finnhub.io/api/news?id=e18f1aad372002f6f1de6bb282fbff19302e111480270217bdb79caea5beae70"
    }
  },
  {
    "ts": null,
    "headline": "Truist Raises L3Harris Technologies’ (LHX) Price Target to $353, Maintains Buy Rating",
    "summary": "L3Harris Technologies Inc. (NYSE:LHX) is one of the best defense stocks in Goldman Sachs’ portfolio. On October 15, Truist Securities raised its price target on L3Harris Technologies (NYSE:LHX) to $353 from $302, while maintaining a Buy rating ahead of the sector’s third-quarter earnings season. The firm notes that the demand environment and broader sentiment for the […]",
    "url": "https://finnhub.io/api/news?id=ce85bdcca3bbce8552d0b8bf2c0af929f31d85f41618428911fc12a95beea987",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761039411,
      "headline": "Truist Raises L3Harris Technologies’ (LHX) Price Target to $353, Maintains Buy Rating",
      "id": 137178458,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "L3Harris Technologies Inc. (NYSE:LHX) is one of the best defense stocks in Goldman Sachs’ portfolio. On October 15, Truist Securities raised its price target on L3Harris Technologies (NYSE:LHX) to $353 from $302, while maintaining a Buy rating ahead of the sector’s third-quarter earnings season. The firm notes that the demand environment and broader sentiment for the […]",
      "url": "https://finnhub.io/api/news?id=ce85bdcca3bbce8552d0b8bf2c0af929f31d85f41618428911fc12a95beea987"
    }
  },
  {
    "ts": null,
    "headline": "Truist Lowers PT on Vericel Corporation (VCEL) to $41 From $46",
    "summary": "Vericel Corporation (NASDAQ:VCEL) is one of the best small cap stocks with the highest upside. On October 15, Truist lowered the price target on Vericel Corporation (NASDAQ:VCEL) to $41 from $46 while keeping a Buy rating on the shares. The rating update was released as part of a broader research note that previewed Q3 results […]",
    "url": "https://finnhub.io/api/news?id=44126472a48c750b108a8b08344e94e6481255c1ae8e47c5d6fcc343aa374682",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761016124,
      "headline": "Truist Lowers PT on Vericel Corporation (VCEL) to $41 From $46",
      "id": 137174640,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Vericel Corporation (NASDAQ:VCEL) is one of the best small cap stocks with the highest upside. On October 15, Truist lowered the price target on Vericel Corporation (NASDAQ:VCEL) to $41 from $46 while keeping a Buy rating on the shares. The rating update was released as part of a broader research note that previewed Q3 results […]",
      "url": "https://finnhub.io/api/news?id=44126472a48c750b108a8b08344e94e6481255c1ae8e47c5d6fcc343aa374682"
    }
  },
  {
    "ts": null,
    "headline": "Truist Lowers PT on PROCEPT BioRobotics Corporation (PRCT) to $50 From $64, Keeps a Buy Rating",
    "summary": "PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the best small cap stocks with the highest upside. On October 15, Truist slashed the price target on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) to $50 from $64 while maintaining a Buy rating on the shares. The rating update came as part of a broader research note previewing the fiscal […]",
    "url": "https://finnhub.io/api/news?id=03130f6fee9b2c87b37382629e2f4bee42570f2cd5d39f5a88db2093acfe926f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761016120,
      "headline": "Truist Lowers PT on PROCEPT BioRobotics Corporation (PRCT) to $50 From $64, Keeps a Buy Rating",
      "id": 137174641,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the best small cap stocks with the highest upside. On October 15, Truist slashed the price target on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) to $50 from $64 while maintaining a Buy rating on the shares. The rating update came as part of a broader research note previewing the fiscal […]",
      "url": "https://finnhub.io/api/news?id=03130f6fee9b2c87b37382629e2f4bee42570f2cd5d39f5a88db2093acfe926f"
    }
  },
  {
    "ts": null,
    "headline": "Janux Therapeutics (JANX) Gets Initiated With a Buy Rating at Truist Financial",
    "summary": "Janux Therapeutics, Inc. (NASDAQ:JANX) is one of the best small cap stocks with the highest upside. Janux Therapeutics, Inc. (NASDAQ:JANX) was initiated with a Buy rating at Truist Financial on October 7. The firm assigned a $100 price target to the stock and cited its proprietary platforms, TRACTr and TRACIr, stating that it believes them […]",
    "url": "https://finnhub.io/api/news?id=ae8a48d9a542c379b135b8720e5d47b8dba690438cbb2f0ce3e29fa8aedb5ba9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761016113,
      "headline": "Janux Therapeutics (JANX) Gets Initiated With a Buy Rating at Truist Financial",
      "id": 137174642,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Janux Therapeutics, Inc. (NASDAQ:JANX) is one of the best small cap stocks with the highest upside. Janux Therapeutics, Inc. (NASDAQ:JANX) was initiated with a Buy rating at Truist Financial on October 7. The firm assigned a $100 price target to the stock and cited its proprietary platforms, TRACTr and TRACIr, stating that it believes them […]",
      "url": "https://finnhub.io/api/news?id=ae8a48d9a542c379b135b8720e5d47b8dba690438cbb2f0ce3e29fa8aedb5ba9"
    }
  },
  {
    "ts": null,
    "headline": "Keefe, Bruyette & Woods Maintains Truist Financial (TFC) Market Perform Recommendation",
    "summary": "Keefe, Bruyette & Woods Maintains Truist Financial (TFC) Market Perform Recommendation",
    "url": "https://finnhub.io/api/news?id=a585dce6b57c506e1b449981477d6c59b46f283e4db5eacdf5407ad60b28f55a",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761005394,
      "headline": "Keefe, Bruyette & Woods Maintains Truist Financial (TFC) Market Perform Recommendation",
      "id": 137171292,
      "image": "",
      "related": "TFC",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=a585dce6b57c506e1b449981477d6c59b46f283e4db5eacdf5407ad60b28f55a"
    }
  },
  {
    "ts": null,
    "headline": "Morgan Stanley Maintains Truist Financial (TFC) Equal-Weight Recommendation",
    "summary": "Morgan Stanley Maintains Truist Financial (TFC) Equal-Weight Recommendation",
    "url": "https://finnhub.io/api/news?id=dc6c1a7ea2b572116f68ae629b94359aa08e9ab98d149745c58168d730d0b774",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761005358,
      "headline": "Morgan Stanley Maintains Truist Financial (TFC) Equal-Weight Recommendation",
      "id": 137171300,
      "image": "",
      "related": "TFC",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=dc6c1a7ea2b572116f68ae629b94359aa08e9ab98d149745c58168d730d0b774"
    }
  }
]